StockTipsArenaBeta

BUY Niva Bupa Health Insurance Company Limited — Sharad Avasthi, SMIFS

BUYNiva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company share price target & all analyst calls

bySharad Avasthi, SMIFSHorizon: 1 year19 Oct 2026via CNBC Awaaz.

Entry₹76.35Inferred
Target₹100
Total upside +30.98%
Stop lossNot given
CMP₹78.771d ago
Active+3.17%+26.95%upside left 11 mo left
Follow Sharad Avasthi for new callsGet alertsWatch NIVABUPA for new buy/sell callsGet alertsSee 3 other Long-term calls on NIVABUPASee 273 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:39 am IST
8 supporting8 neutral3 opposing
Supports the BUY call (8)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·13 Nov · yesterday

2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·6 Nov · 1w ago

Niva Bupa reported strong Q2 FY27 results with a 35% growth in Gross Written Premium to 2,484 crores and a 124% increase in Profit After Tax to 136 crores.

BSE · Company Update·4 Nov · 1w ago

(opens in new tab)

Niva Bupa reported strong Q2 FY27 results with a 35% growth in Gross Written Premium to 2,484 crores and a 124% increase in Profit After Tax to 136 crores.

NSE · Press Release·4 Nov · 1w ago

(opens in new tab)

Niva Bupa Health Insurance reported unaudited financial results for the quarter and half-year ended September 30, 2026, showing a profit of Rs 13,564 lakhs for the quarter.

BSE · Board Meeting·4 Nov · 1w ago

(opens in new tab)
Neutral / worth noting (8)

Niva Bupa Health Insurance Company Limited reported unaudited financial results for the quarter and half year ended September 30, 2026.

NSE · Outcome of Board Meeting·4 Nov · 1w ago

(opens in new tab)
Weighs against the BUY call (3)

1 advisor has an active short-term SELL call on this stock

Advisor consensus · adjacent horizon·29 Sept · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Niva Bupa Health Insurance Company

All analyst calls on Niva Bupa Health Insurance Company

More from Sharad Avasthi, SMIFS

Every call and its outcome